default author photo

Wen-Yan Wan

Government of the People's Republic of China - National Institutes for Food and Drug Control

Beijing

China

SCHOLARLY PAPERS

2

DOWNLOADS

204

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Immunogenicity and Safety of a Recombinant gE-Fc Fusion Protein Subunit Vaccine for Herpes Zoster in Adults ≥50 Years of Age: A Randomised, Active-Controlled, Non-Inferiority Trial

Number of pages: 30 Posted: 09 Apr 2025
Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Government of the People's Republic of China - National Institutes for Food and Drug Control, Wuxi Centre for Disease Control and Prevention, Beijing Luzhu Biotechnology Co., Ltd., Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Nanjing Medical University, Wuxi Centre for Disease Control and Prevention, Beijing Luzhu Biotechnology Co., Ltd., Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Southeast University - School of Public Health, Government of the People's Republic of China - National Institutes for Food and Drug Control, Wuxi Centre for Disease Control and Prevention, Wuxi Centre for Disease Control and Prevention, Government of the People's Republic of China - National Institutes for Food and Drug Control, Government of the People's Republic of China - National Institutes for Food and Drug Control, Southeast University - School of Public Health, Southeast University - School of Public Health, Yunnan University, Yunnan University, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Beijing Luzhu Biotechnology Co., Ltd., China Pharmaceutical University - State Key Laboratory of Natural Medicines, National Institutes for Food and Drug Control and Nanjing Medical University
Downloads 139 (527,599)

Abstract:

Loading...

Herpes zoster, gE-Fc fusion vaccine, subunit vaccine, immunogenicity, safety, non-inferiority trial

2.

The Efficacy, Immunogenicity and Safety of a Recombinant Tetrameric GE-FC Fusion Protein Vaccine for Herpes Zoster in Adults 40 Years of Age or Older: A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial

Number of pages: 40 Posted: 12 Nov 2025
Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Government of the People's Republic of China - National Institutes for Food and Drug Control, Shanxi Provincial Center for Disease Control and Prevention, Nanjing Medical University - School of Public Health, Southeast University - School of Public Health, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Hubei Provincial Center for Disease Control and Prevention, Shanxi Provincial Center for Disease Control and Prevention, Shandong Provincial Center for Disease Control and Prevention, Hubei Provincial Center for Disease Control and Prevention, Shandong Provincial Center for Disease Control and Prevention, Compang of Tigermed, Government of the People's Republic of China - National Institutes for Food and Drug Control, Government of the People's Republic of China - National Institutes for Food and Drug Control, Hubei Provincial Center for Disease Control and Prevention, Shandong Provincial Center for Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Nanjing Medical University and Independent
Downloads 65 (916,100)

Abstract:

Loading...

Recombinant gE-Fc fusion protein adjuvanted with aluminum hydroxide, vaccine, Efficacy, immunogenicity, Safety